BIOAGE LABS INC (BIOA) Institutional Shareholders

BIOAGE LABS INC (BIOA) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $900.73M in BIOA holdings during the latest filing period.

A16Z Capital Management, L.L.C. is currently the largest disclosed institutional shareholder of BIOA tracked by InsiderSet, reporting ownership valued at approximately $79.24M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $26.06M, representing an estimated loss of -67.12% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 54% of the total disclosed BIOA value among the investors covered in this analysis. Major shareholders include A16Z Capital Management, L.L.C., Blackrock, Inc., Cormorant Asset Management, Lp, and several other long-term asset managers with concentrated positions in BIOAGE LABS INC (BIOA).

This page ranks the largest institutional BIOA shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

149

Total Reported Value

$900.73M

Largest Holder

A16Z Capital Management, L.L.C.

Largest Position

$79.24M

Insider Transactions (90d)

0

Latest Filing Quarter

Q2 2026

New Institutional Positions

128

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
A16Z Capital Management, L.L.C.0.56%3,233,170$79,244,997$26,059,350-$53,185,647-67.12%
Blackrock, Inc.0.00%2,849,077$69,830,877$22,963,561-$46,867,316-67.12%
Cormorant Asset Management, Lp3.00%2,390,605$58,593,729$19,268,276-$39,325,453-67.12%
Sofinnova Investments, Inc.3.00%2,293,788$56,220,744$18,487,931-$37,732,813-67.12%
Octagon Capital Advisors Lp3.93%1,748,000$42,843,480$14,088,880-$28,754,600-67.12%
Ra Capital Management, L.P.0.36%1,671,648$40,972,092$13,473,483-$27,498,609-67.12%
Mpm Bioimpact Llc2.49%1,667,661$40,874,371$13,441,348-$27,433,023-67.12%
Vanguard Capital Management Llc0.00%1,544,214$37,848,685$12,446,365-$25,402,320-67.12%
Janus Henderson Group Plc0.02%2,094,270$36,597,368$16,879,816-$19,717,552-53.88%
Polar Capital Holdings Plc0.07%1,072,344$26,283,151$8,643,093-$17,640,058-67.12%
Braidwell Lp0.94%1,033,129$25,321,992$8,327,020-$16,994,972-67.12%
State Street Corp0.00%1,021,464$25,036,083$8,233,000-$16,803,083-67.12%
Geode Capital Management, Llc0.00%1,004,264$24,619,235$8,094,368-$16,524,867-67.12%
Sands Capital Alternatives, Llc3.14%786,353$19,273,512$6,338,005-$12,935,507-67.12%
Orbimed Advisors Llc0.35%752,153$18,435,270$6,062,353-$12,372,917-67.12%
D. E. Shaw & Co., Inc.0.01%742,761$18,205,072$5,986,654-$12,218,418-67.12%
Balyasny Asset Management L.P.0.03%702,858$17,227,050$5,665,035-$11,562,015-67.12%
Pivotal Bioventure Partners Investment Advisor Llc5.20%653,374$16,014,197$5,266,194-$10,748,003-67.12%
Cosmic Management, Llc3.22%501,833$12,299,927$4,044,774-$8,255,153-67.12%
Stempoint Capital Lp1.97%464,171$11,376,831$3,741,218-$7,635,613-67.12%
Vanguard Portfolio Management Llc0.00%410,165$10,053,144$3,305,930-$6,747,214-67.12%
Dimensional Fund Advisors Lp0.00%394,138$9,661,958$3,176,752-$6,485,206-67.12%
Jacobs Levy Equity Management, Inc0.03%377,085$9,242,353$3,039,305-$6,203,048-67.12%
Walleye Capital Llc0.04%354,395$8,686,221$2,856,424-$5,829,797-67.12%
Nuveen, Llc0.00%349,142$8,557,471$2,814,085-$5,743,386-67.12%
Northern Trust Corp0.00%343,166$8,410,999$2,765,918-$5,645,081-67.12%
Adage Capital Partners Gp, L.L.C.0.01%300,000$7,353,000$2,418,000-$4,935,000-67.12%
Integral Health Asset Management, Llc0.30%300,000$7,353,000$2,418,000-$4,935,000-67.12%
Morgan Stanley0.00%282,386$6,921,282$2,276,031-$4,645,251-67.12%
Charles Schwab Investment Management Inc0.00%273,371$6,700,323$2,203,370-$4,496,953-67.12%
Comprehensive Financial Management Llc0.22%271,842$6,662,847$2,191,047-$4,471,800-67.12%
Goldman Sachs Group Inc0.00%270,769$6,636,548$2,182,398-$4,454,150-67.12%
Bank Of America Corp0.00%257,855$6,320,026$2,078,311-$4,241,715-67.12%
Jpmorgan Chase & Co0.00%233,979$5,837,776$1,885,871-$3,951,905-67.70%
Acadian Asset Management Llc0.01%224,453$5,499,000$1,809,091-$3,689,909-67.10%
Millennium Management Llc0.00%222,621$5,456,441$1,794,325-$3,662,116-67.12%
Vanguard Fiduciary Trust Co0.00%219,600$5,382,396$1,769,976-$3,612,420-67.12%
Sphera Funds Management Ltd.0.75%213,671$5,237,076$1,722,188-$3,514,888-67.12%
Ikarian Capital, Llc0.80%200,000$4,901,999$1,612,000-$3,289,999-67.12%
Fmr Llc0.00%183,563$4,499,129$1,479,518-$3,019,611-67.12%
Yiheng Capital Management, L.P.1.78%170,532$4,179,739$1,374,488-$2,805,251-67.12%
Renaissance Technologies LLCJim Simons0.01%165,700$4,061,307$1,335,542-$2,725,765-67.12%
Squadron Capital Management Llc1.30%155,000$3,799,050$1,249,300-$2,549,750-67.12%
Diadema Partners Lp1.27%146,334$3,586,646$1,179,452-$2,407,194-67.12%
Invesco Ltd.0.00%127,420$3,123,064$1,027,005-$2,096,059-67.12%
Ensign Peak Advisors, Inc0.01%166,224$2,907,258$1,339,765-$1,567,493-53.92%
Bank Of New York Mellon Corp0.00%107,332$2,630,698$865,096-$1,765,602-67.12%
Ubs Group Ag0.00%102,926$2,522,716$829,584-$1,693,132-67.12%
Nextbio Capital Management Lp1.14%100,732$2,468,941$811,900-$1,657,041-67.12%
Burkehill Global Management, Lp0.09%100,000$2,451,000$806,000-$1,645,000-67.12%
Showing 50 of 149

Frequently asked questions about BIOA

  • Who owns the most BIOA stock?

    The largest holders of BIOA are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for BIOAGE LABS INC (BIOA).

  • Is BIOA widely held by superinvestors?

    Many widely followed stocks like BIOA appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly BIOA is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.